Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

RTVUE MODEL RTVUE 100

K-Number: K101505 · 2010-09-15

ApplicantOptovue, Inc.
Decision Date2010-09-15
Product CodeHLI
Advisory CommitteeOP
DecisionSubstantially Equivalent

Device Summary

RTVUE MODEL RTVUE 100 is the device name listed in this FDA 510(k) record. The listed applicant is Optovue, Inc.. It received FDA 510(k) clearance on 2010-09-15 under 510(k) number K101505. The device is classified under product code HLI. It was reviewed by the OP advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the RTVUE MODEL RTVUE 100?

RTVUE MODEL RTVUE 100 is a medical device that received FDA 510(k) clearance on 2010-09-15. The listed applicant is Optovue, Inc.. The 510(k) number is K101505.

When did RTVUE MODEL RTVUE 100 receive FDA 510(k) clearance?

RTVUE MODEL RTVUE 100 received FDA 510(k) clearance on 2010-09-15, under 510(k) number K101505.

Who is the listed applicant for RTVUE MODEL RTVUE 100?

The FDA 510(k) record lists Optovue, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for RTVUE MODEL RTVUE 100?

The FDA product code for RTVUE MODEL RTVUE 100 is HLI.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing Optovue, Inc. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K222166SOLIXK180660AvantiK163475iVueK153080RTVue XR OCT Avanti with AngioVue SoftwareK130656IFUSIONK121739IVUE WITH NORMATIVE DATABASE

View all 15 devices →

Related Devices (Code: HLI)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K153080RTVue XR OCT Avanti with AngioVue SoftwareOptovue, Inc.K123316HEINE OMEGA 500Heine Optotechnik GmbH & Co. KGK121739IVUE WITH NORMATIVE DATABASEOptovue, Inc.K120057ENVISU SPECTRAL DOMAIN OPHTHALMIC IMAGING SYSTEM (SDOIS)Bioptigen, Inc.K120238RTVUE XR OCTOptovue, Inc.K111531RHA2020Annidis Health Systems Corp.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑